Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biocardia Inc (BCDA)

Biocardia Inc (BCDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,753
  • Shares Outstanding, K 16,793
  • Annual Sales, $ 150 K
  • Annual Income, $ -15,000 K
  • 60-Month Beta 1.82
  • Price/Sales 392.61
  • Price/Cash Flow N/A
  • Price/Book 3.07
Trade BCDA with:

Options Overview

Details
  • Implied Volatility 84.06%
  • Historical Volatility 59.04%
  • IV Percentile 32%
  • IV Rank 15.07%
  • IV High 299.02% on 03/16/21
  • IV Low 45.92% on 05/19/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 1,302
  • Open Int (30-Day) 1,480

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.21
  • Number of Estimates 2
  • High Estimate -0.18
  • Low Estimate -0.23
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +54.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.22 +4.97%
on 07/27/21
3.87 -12.66%
on 07/06/21
-0.48 (-12.44%)
since 07/02/21
3-Month
3.22 +4.97%
on 07/27/21
5.10 -33.71%
on 06/21/21
-0.16 (-4.52%)
since 04/30/21
52-Week
1.91 +76.96%
on 11/06/20
8.60 -60.70%
on 12/15/20
+0.88 (+35.20%)
since 07/31/20

Most Recent Stories

More News
BioCardia Announces Japanese Patent on Imaging System for Targeting Cardiac Therapies

BioCardia(R), Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Japan Patent Office has...

BCDA : 3.41 (+2.71%)
BioCardia Announces Fourth Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed

BioCardia(R), Inc. [Nasdaq: BCDA], a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces that the independent...

BCDA : 3.41 (+2.71%)
BioCardia to Present CardiAMP Cell Therapy Clinical Trial Data at European Society of Cardiology Heart Failure 2021

BioCardia(R), Inc. [Nasdaq: BCDA], a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces data from its CardiAMP...

BCDA : 3.41 (+2.71%)
BioCardia Announces European Patent Office Decision to Grant Patent on Autologous Cell Therapy Patient Selection Diagnostic Assay

BioCardia, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that the European patent office has...

BCDA : 3.41 (+2.71%)
BioCardia to Be Added to the Russell Microcap(R) Index

BioCardia(R), Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies, today announced it is to join the Russell Microcap Index....

BCDA : 3.41 (+2.71%)
BioCardia to Present at the LD Micro Virtual Invitational Conference on June 8, 2021

BioCardia(R), Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies, announced today that Chief Executive Officer Peter Altman...

BCDA : 3.41 (+2.71%)
BioCardia, Inc. (BCDA) Reports Q1 Loss, Tops Revenue Estimates

BioCardia, Inc. (BCDA) delivered earnings and revenue surprises of 14.29% and 31.43%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

BCDA : 3.41 (+2.71%)
BioCardia Reports First Quarter 2021 Financial Results and Business Highlights

BioCardia, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies, today reported financial results for the first quarter of 2021...

BCDA : 3.41 (+2.71%)
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates

BioCardia(R), Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with a leading Japanese biotechnology company related to BioCardia Helix catheter biotherapeutic delivery product...

BCDA : 3.41 (+2.71%)
BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates

BioCardia, Inc. (BCDA) delivered earnings and revenue surprises of 48.39% and -58.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

BCDA : 3.41 (+2.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California....

See More

Key Turning Points

3rd Resistance Point 3.54
2nd Resistance Point 3.47
1st Resistance Point 3.40
Last Price 3.41
1st Support Level 3.26
2nd Support Level 3.19
3rd Support Level 3.12

See More

52-Week High 8.60
Fibonacci 61.8% 6.04
Fibonacci 50% 5.26
Fibonacci 38.2% 4.47
Last Price 3.41
52-Week Low 1.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar